Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Diana G. Ferreira"'
Autor:
Paulo, Martins, Björn, Vandewalle, Jorge, Félix, Carlos M, Capela, João J, Cerqueira, António V, Salgado, Diana G, Ferreira, Isabel, Monteiro
Publikováno v:
PharmacoEconomics - open.
Ocrelizumab demonstrated significant clinical benefit for the treatment of relapsing (RMS) and primary progressive (PPMS) multiple sclerosis (MS), an incurable disease characterized by disability progression. This study evaluated the clinical and eco
Autor:
Nadia A Rivero-Segura, Edgar Flores-Soto, Selene García de la Cadena, Isabel Coronado-Mares, Juan C Gomez-Verjan, Diana G Ferreira, Erika Alejandra Cabrera-Reyes, Luísa V Lopes, Lourdes Massieu, Marco Cerbón
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176910 (2017)
Prolactin (PRL) is a peptidic hormone that displays pleiotropic functions in the organism including different actions in the brain. PRL exerts a neuroprotective effect against excitotoxicity produced by glutamate (Glu) or kainic acid in both in vitro
Externí odkaz:
https://doaj.org/article/7a7bb504fde74947a6245be0c1e45d1d
Autor:
Joana E Coelho, Pedro eAlves, Paula M Canas, Jorge S Valadas, Vania L Batalha, Diana G Ferreira, Tatiana eShmidt, Joaquim Alexandre Ribeiro, Michael eBader, Rodrigo A Cunha, Frederico eSimões do Couto, Luisa V Lopes
Publikováno v:
Frontiers in Psychiatry, Vol 5 (2014)
Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well established in motor
Externí odkaz:
https://doaj.org/article/6c5182f2b39245c2af7661390804b0d5
Autor:
Diana G. Ferreira, Wei Xiang, Hugo Vicente Miranda, Nuno C. Santos, Luís M. A. Oliveira, Irina Zamolo, Deborah Penque, Olaf Riess, Ruth Rott, Flaviano Giorgini, Carlos Cordeiro, Márcia Oliveira, Marcos António Gomes, Ekrem Darendelioglu, Luísa V. Lopes, Tiago F. Outeiro, Carlo Breda, Alexandre Quintas, Eva F. Rodrigues, Éva M. Szegő, Markus Zweckstetter, Hilal A. Lashuel, Michael Heinrich, Tânia Simões, Rita Oliveira, Ivo C. Martins, Thomas M. Jovin, Francisco J. Enguita, Jochen Klucken, Francesca Munari, Simone Engelender, Ana Ponces-Freire
Publikováno v:
Brain. 144:e58-e58
Autor:
Joana E. Coelho, Tiago F. Outeiro, Mariana Temido-Ferreira, Inga Zerr, Jeong-Seop Rhee, Matthias Schmitz, Éva M. Szegö, Sandra H. Vaz, Diana G. Ferreira, Vânia L. Batalha, Hugo Vicente Miranda, Luísa V. Lopes, Inês Marques-Morgado
Publikováno v:
Nature reviews / Neuroscience 20(11), 1569-1579 (2017). doi:10.1038/nn.4648
Nature Neuroscience
Nature Neuroscience
© 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders that are characterized by the accumulation of α-synuclein
Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders that are characterized by the accumulation of α-synuclein
Autor:
Francisco M. Mouro, Luísa V. Lopes, Ana M. Sebastião, Joana E. Coelho, Younis Baqi, Christa E. Müller, Vânia L. Batalha, Joaquim A. Ribeiro, Diana G. Ferreira
Publikováno v:
Neuropharmacology
© 2017 Elsevier Ltd. All rights reserved.
Cannabinoid-mediated memory impairment is a concern in cannabinoid-based therapies. Caffeine exacerbates cannabinoid CB1 receptor (CB1R)-induced memory deficits through an adenosine A1 receptor-mediated
Cannabinoid-mediated memory impairment is a concern in cannabinoid-based therapies. Caffeine exacerbates cannabinoid CB1 receptor (CB1R)-induced memory deficits through an adenosine A1 receptor-mediated
Autor:
Andreia Pinto, José Pimentel, Michael Bader, Rodrigo A. Cunha, Luísa V. Lopes, Rui Gomes, Christa E. Müller, Inês Marques-Morgado, Vânia L. Batalha, Joana E. Coelho, Pedro M. Pereira, Laetitia Cuvelier, Tiago F. Outeiro, Diana G. Ferreira, Younis Baqi, Paula A. Pousinha, David Blum, Emilie Faivre, Serge N. Schiffmann, Luc Buée, Hélène Marie, Sara Carvalho, Mariana Temido-Ferreira, Valérie Buée-Scherrer, Paula M. Canas
Publikováno v:
Molecular Psychiatry
Molecular Psychiatry, Nature Publishing Group, 2018, ⟨10.1038/s41380-018-0110-9⟩
Molecular Psychiatry, 2018, ⟨10.1038/s41380-018-0110-9⟩
Molecular psychiatry, 25 (8
Molecular Psychiatry, Nature Publishing Group, 2018, ⟨10.1038/s41380-018-0110-9⟩
Molecular Psychiatry, 2018, ⟨10.1038/s41380-018-0110-9⟩
Molecular psychiatry, 25 (8
© The Author(s) 2018. This article is published with open access. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any mediu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b10a7b64b9f6f27e03756e908d6ecd
https://hdl.handle.net/10451/55389
https://hdl.handle.net/10451/55389
Autor:
Carlos Cordeiro, Luís M. A. Oliveira, Ruth Rott, Deborah Penque, Tania Simões, Michael Heinrich, Francesca Munari, Ekrem Darendelioglu, Olaf Riess, Carlo Breda, Diana G. Ferreira, Thomas M. Jovin, Rita Machado de Oliveira, Luísa V. Lopes, Eva F. Rodrigues, Ivo C. Martins, Hugo Vicente Miranda, Jochen Klucken, Markus Zweckstetter, Hilal A. Lashuel, Alexandre Quintas, Márcia Oliveira, Nuno C. Santos, Marcos António Gomes, Tiago F. Outeiro, Irina Zamolo, Wei Xiang, Simone Engelender, Ana Ponces-Freire, Francisco J. Enguita, Éva M. Szegö, Flaviano Giorgini
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Brain
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
Brain 140(5), 1399-1419 (2017). doi:10.1093/brain/awx056
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Brain
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
Brain 140(5), 1399-1419 (2017). doi:10.1093/brain/awx056
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases kn
α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases kn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50ba62720be24e704cb583505996af7
Autor:
Erika Alejandra Cabrera-Reyes, Nadia Alejandra Rivero-Segura, Luísa V. Lopes, Marco Cerbón, Diana G. Ferreira, Isabel Coronado-Mares, Juan Carlos Gomez-Verjan, Lourdes Massieu, Selene García de la Cadena, Edgar Flores-Soto
Publikováno v:
PLOS ONE
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176910 (2017)
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176910 (2017)
Prolactin (PRL) is a peptidic hormone that displays pleiotropic functions in the organism including different actions in the brain. PRL exerts a neuroprotective effect against excitotoxicity produced by glutamate (Glu) or kainic acid in both in vitro
Autor:
Diana G, Ferreira, Mariana, Temido-Ferreira, Hugo, Vicente Miranda, Vânia L, Batalha, Joana E, Coelho, Éva M, Szegö, Inês, Marques-Morgado, Sandra H, Vaz, Jeong Seop, Rhee, Matthias, Schmitz, Inga, Zerr, Luísa V, Lopes, Tiago F, Outeiro
Publikováno v:
Nature neuroscience. 20(11)
Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders that are characterized by the accumulation of α-synuclein (aSyn) in intracellular inclusions known as Lewy bodies. Prefibrillar soluble aSy